This website uses own and third party cookies to give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Accept More information




Publications<< Back

Rigol M, Solanes N, Farré J, Roura S, Roqué M, Berruezo A, Bellera N, Novensá L, Tamborero D, Prat-Vidal C, Huzman MA, Batlle M, Hoefsloot M, Sitges M, Ramírez J, Dantas AP, Merino A, Sanz G, Brugada J, Bayés-Genís A, Heras M

Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration.

J. Card. Fail.. 2010 Apr;16(4):357-66, PMID: 20350704

Cell-based therapies offer a promising approach to reducing the short-term mortality rate associated with heart failure after a myocardial infarction. The aim of the study was to analyze histological and functional effects of adipose tissue-derived stem cells (ADSCs) after myocardial infarction and compare 2 types of administration pathways.

CARDIAC & CARDIOVASCULAR SYSTEMS

An initiative of

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar